Teleflex Awarded National Group Purchasing Agreement with Premier to Expand Access to Advanced Vascular Access Solutions
Teleflex Incorporated, a global provider of medical technologies designed to improve patient care and clinical outcomes, has announced that it has been awarded a new national group purchasing agreement with Premier, Inc. for its portfolio of central venous access products. The agreement, which became effective on July 1, 2026, enables Premier member healthcare organizations to access a wide range of Teleflex vascular access solutions through specially negotiated pricing and contract terms.
The partnership represents an important milestone for Teleflex as it continues expanding access to its Arrow™ portfolio of vascular access technologies across hospitals and healthcare systems throughout the United States. Under the agreement, Premier members may choose to purchase a variety of Teleflex products, including short-term central venous catheters, arterial catheter systems, intraosseous vascular access devices, and other specialized vascular access technologies designed to support safe and efficient patient care.
By strengthening its collaboration with one of the nation’s largest healthcare improvement organizations, Teleflex aims to help healthcare providers improve clinical outcomes, standardize vascular access practices, reduce complications, and increase operational efficiency across a wide range of clinical settings.
Supporting Healthcare Systems Through Strategic Collaboration
Group purchasing organizations (GPOs) play an increasingly important role within modern healthcare by helping hospitals and health systems secure high-quality medical products through negotiated national contracts.
Through this new agreement with Premier, Teleflex expands the availability of its vascular access portfolio while allowing Premier member organizations to benefit from pre-negotiated pricing and purchasing terms.
Although participation remains optional, eligible Premier members now have streamlined access to a broad selection of Teleflex vascular access products that support numerous clinical procedures across emergency medicine, critical care, surgery, and intensive care environments.
The collaboration reflects a shared commitment to improving patient care while helping healthcare organizations optimize purchasing efficiency and clinical standardization.
Expanding Access to the Arrow™ Vascular Access Portfolio
The agreement includes several products from Teleflex’s well-established Arrow™ brand, which has served clinicians for more than four decades.
The Arrow™ portfolio has become widely recognized for providing vascular access technologies designed to support clinicians throughout the continuum of patient care.
Products available under the new agreement include:
- Arrowg+ard Blue Plus™ Central Venous Catheters
- Arrow™ ErgoPack™ Complete Systems
- Arrow™ Arterial Catheters and Catheterization Kits
- Arrow™ EZ-IO™ Intraosseous Vascular Access System
- Arrow™ Multi-Lumen Access Catheters (MAC)
- Arrow™ Percutaneous Sheath Introducers (PSI)
Together, these products address a broad range of vascular access needs encountered in hospitals, emergency departments, operating rooms, and intensive care units.
Addressing Critical Clinical Needs
Reliable vascular access is a cornerstone of modern medical care.
Clinicians routinely depend on vascular access devices for administering medications, fluids, blood products, nutrition, and life-saving therapies while also enabling blood sampling and hemodynamic monitoring.
Because these devices are used across virtually every area of hospital medicine, selecting high-quality vascular access technologies is critical for maintaining patient safety and supporting clinical efficiency.
Teleflex has invested extensively in developing products intended to simplify vascular access procedures while reducing complications associated with catheter placement and long-term device use.
The company’s solutions are designed to support both routine and complex clinical situations requiring dependable vascular access.
Focus on Patient Safety
One of the primary goals of the new agreement is expanding access to technologies that help support patient safety.
Among the featured products are Arrowg+ard Blue Plus™ Central Venous Catheters, which incorporate broad-spectrum antimicrobial protection.
These catheters are designed to help reduce the risk of catheter-related bloodstream infections (CRBSIs)—one of the most significant complications associated with central venous catheterization.
Catheter-related bloodstream infections can contribute to:
- Increased patient morbidity
- Longer hospital stays
- Higher healthcare costs
- Additional antibiotic treatment
- Increased healthcare resource utilization
By incorporating antimicrobial technology into catheter design, Teleflex seeks to help healthcare providers reduce infection risk while supporting evidence-based infection prevention strategies.
Promoting Evidence-Based Clinical Practice
Healthcare organizations continue placing increasing emphasis on evidence-based medicine when selecting medical technologies.
According to Teleflex, its vascular access portfolio has been developed to support established clinical guidelines and best practices related to vascular access management.
Through the Premier agreement, healthcare systems will have greater access to products designed to help:
- Support evidence-based vascular access protocols
- Align with recognized clinical guidelines
- Improve procedural consistency
- Enhance patient safety initiatives
- Reduce preventable complications
Standardization around evidence-based products may also contribute to improved training, greater procedural consistency, and more predictable clinical outcomes.
Standardizing Vascular Access Across Care Settings
Hospitals frequently utilize multiple vascular access products across various departments.
Managing numerous product variations can create challenges related to staff training, inventory management, and procedural consistency.
Teleflex believes its comprehensive product portfolio enables healthcare organizations to standardize vascular access technologies across multiple clinical settings.
Standardization may provide several operational advantages, including:
- Simplified staff education
- Consistent clinical protocols
- Improved inventory management
- Reduced product variation
- Enhanced purchasing efficiency
By consolidating product selection around a trusted portfolio, healthcare systems may improve workflow while maintaining consistent standards of patient care.
Supporting Clinical Workflow Efficiency
In addition to improving patient safety, modern healthcare organizations increasingly prioritize operational efficiency.
Healthcare providers continue facing growing demands related to staffing, patient volumes, and resource utilization.
Medical technologies that simplify procedures and improve clinician workflow have therefore become increasingly valuable.
Teleflex states that its Arrow™ vascular access solutions have been developed to support clinicians throughout the entire continuum of care while promoting efficient procedural performance.
Improved workflow efficiency may allow clinicians to spend more time focused on direct patient care while minimizing procedural complexity.
Addressing Healthcare Costs
Complications associated with vascular access devices can significantly increase healthcare costs.
Bloodstream infections, catheter replacement procedures, treatment delays, and extended hospital stays all contribute to increased financial burden for healthcare systems.
Teleflex notes that its product portfolio is designed not only to improve patient care but also to help organizations address costs associated with vascular access complications.
Reducing preventable infections and procedural complications may ultimately support better resource utilization while improving overall healthcare value.
As healthcare reimbursement models continue evolving toward quality-based outcomes, technologies capable of improving safety while controlling costs have become increasingly important.
Teleflex Highlights the Value of the Partnership
Commenting on the agreement, Cris Gomide, Vice President and General Manager of Vascular & Emergency Medicine at Teleflex, emphasized the company’s commitment to supporting healthcare providers through innovative vascular access technologies.
He explained that healthcare systems continue placing greater emphasis on patient safety, product standardization, and operational efficiency.
According to Gomide, the agreement with Premier expands access to Teleflex’s Arrow™ vascular access portfolio while helping clinicians implement evidence-based practices throughout patient care.
He further noted that the company’s technologies are designed to support workflow efficiency while addressing clinical risks associated with vascular access complications.
More Than Four Decades of Innovation
Teleflex has been advancing vascular access technologies through its Arrow™ portfolio for more than 40 years.
Over that time, the company has introduced numerous innovations designed to improve vascular access procedures while supporting healthcare providers across multiple specialties.
Its products are used in:
- Critical care
- Emergency medicine
- Anesthesiology
- Surgery
- Interventional procedures
- Intensive care units
The new Premier agreement builds upon this longstanding history by expanding availability of these technologies to a broader network of healthcare providers nationwide.
Premier’s Role in Healthcare Improvement
Premier, Inc. is one of the largest healthcare improvement organizations in the United States.
The company works closely with hospitals, health systems, suppliers, and payers to improve healthcare quality, efficiency, and affordability.
Its services include:
- Supply chain management
- Data analytics
- Healthcare technology
- Clinical collaboratives
- Advisory services
- Operational improvement solutions
By negotiating national purchasing agreements, Premier enables member organizations to access high-quality medical products while supporting cost-effective procurement strategies.
The partnership with Teleflex aligns with Premier’s broader mission of helping healthcare providers deliver better patient outcomes through improved access to innovative medical technologies.
The national group purchasing agreement between Teleflex and Premier represents an important step toward expanding access to advanced vascular access technologies across hospitals and healthcare systems throughout the United States. By making the Arrow™ portfolio available through pre-negotiated pricing and contract terms, the collaboration supports healthcare organizations seeking to improve patient safety, standardize clinical practices, and enhance operational efficiency.
As healthcare providers continue focusing on evidence-based care, infection prevention, and cost-effective resource management, access to comprehensive vascular access solutions remains an essential component of modern clinical practice. Through this agreement, Teleflex reinforces its longstanding commitment to innovation in vascular access while supporting clinicians with technologies designed to improve procedural performance, reduce complications, and promote high standards of patient care. At the same time, the partnership underscores the shared objective of Teleflex and Premier to help healthcare organizations deliver safer, more efficient, and higher-quality care for patients across a broad range of medical settings.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management’s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.